184 related articles for article (PubMed ID: 34850111)
1. A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations.
Zaurin R; Ferrari R; Nacht AS; Carbonell J; Le Dily F; Font-Mateu J; de Llobet Cucalon LI; Vidal E; Lioutas A; Beato M; Vicent GP
Nucleic Acids Res; 2021 Dec; 49(22):12716-12731. PubMed ID: 34850111
[TBL] [Abstract][Full Text] [Related]
2. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
4. CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.
Vallejo G; La Greca AD; Tarifa-Reischle IC; Mestre-Citrinovitz AC; Ballaré C; Beato M; Saragüeta P
PLoS One; 2014; 9(5):e97311. PubMed ID: 24859236
[TBL] [Abstract][Full Text] [Related]
5. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
8. C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.
Nacht AS; Ferrari R; Zaurin R; Scabia V; Carbonell-Caballero J; Le Dily F; Quilez J; Leopoldi A; Brisken C; Beato M; Vicent GP
EMBO J; 2019 Sep; 38(18):e101426. PubMed ID: 31373033
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).
Chen CC; Hardy DB; Mendelson CR
J Biol Chem; 2011 Dec; 286(50):43091-102. PubMed ID: 22020934
[TBL] [Abstract][Full Text] [Related]
10. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
11. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.
Yu S; Kim T; Yoo KH; Kang K
Biochem Biophys Res Commun; 2017 May; 486(3):752-758. PubMed ID: 28342866
[TBL] [Abstract][Full Text] [Related]
12. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.
McFall T; Patki M; Rosati R; Ratnam M
Oncotarget; 2015 Oct; 6(32):33146-64. PubMed ID: 26356672
[TBL] [Abstract][Full Text] [Related]
13. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
14. Multimodal regulation of E2F1 gene expression by progestins.
Wade HE; Kobayashi S; Eaton ML; Jansen MS; Lobenhofer EK; Lupien M; Geistlinger TR; Zhu W; Nevins JR; Brown M; Otteson DC; McDonnell DP
Mol Cell Biol; 2010 Apr; 30(8):1866-77. PubMed ID: 20123965
[TBL] [Abstract][Full Text] [Related]
15. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor modulates ERα action in breast cancer.
Mohammed H; Russell IA; Stark R; Rueda OM; Hickey TE; Tarulli GA; Serandour AA; Birrell SN; Bruna A; Saadi A; Menon S; Hadfield J; Pugh M; Raj GV; Brown GD; D'Santos C; Robinson JL; Silva G; Launchbury R; Perou CM; Stingl J; Caldas C; Tilley WD; Carroll JS
Nature; 2015 Jul; 523(7560):313-7. PubMed ID: 26153859
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
18. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
Nardulli AM; Katzenellenbogen BS
Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.
Clare SE; Gupta A; Choi M; Ranjan M; Lee O; Wang J; Ivancic DZ; Kim JJ; Khan SA
BMC Cancer; 2016 May; 16():326. PubMed ID: 27215412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]